Free Trial

Omnicell (OMCL) Financials

Omnicell logo
$29.61 +1.38 (+4.89%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$29.60 0.00 (-0.02%)
As of 05/27/2025 04:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Omnicell

Annual Income Statements for Omnicell

This table shows Omnicell's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Income / (Loss) Attributable to Common Shareholders
13 -20 5.65 78 32 61 38 31 9.76 31 31
Consolidated Net Income / (Loss)
13 -20 5.65 78 32 61 38 31 9.76 31 31
Net Income / (Loss) Continuing Operations
13 -20 5.65 78 32 61 38 31 9.76 31 31
Total Pre-Tax Income
26 -20 -2.45 66 29 74 36 4.51 13 46 49
Total Operating Income
0.34 -35 -2.32 90 36 78 44 11 21 49 50
Total Gross Profit
471 497 589 555 413 437 372 319 317 248 234
Total Revenue
1,112 1,147 1,296 1,132 892 897 787 713 696 485 441
Operating Revenue
1,112 1,147 1,296 1,132 892 897 787 713 696 485 441
Total Cost of Revenue
641 650 707 577 479 460 415 394 379 237 207
Operating Cost of Revenue
641 650 707 577 479 460 415 394 379 237 207
Total Operating Expenses
471 532 591 465 378 359 328 307 296 199 184
Selling, General & Admin Expense
380 435 486 389 308 290 263 241 238 168 156
Research & Development Expense
90 97 105 76 70 69 65 66 58 35 28
Total Other Income / (Expense), net
25 15 -0.13 -24 -6.18 -4.42 -8.78 -6.63 -8.43 -2.39 -1.08
Other Income / (Expense), net
25 15 -0.13 -24 -6.18 -4.42 -8.78 -6.63 -8.43 -2.39 -1.08
Income Tax Expense
13 0.26 -8.10 -12 -2.85 13 -2.11 -26 3.22 15 18
Basic Earnings per Share
$0.27 ($0.45) $0.13 $1.79 $0.76 $1.48 $0.96 $0.81 $0.27 $0.86 $0.86
Weighted Average Basic Shares Outstanding
46.05M 45.21M 44.40M 43.48M 42.58M 41.46M 39.24M 37.48M 36.16M 35.86M 35.65M
Diluted Earnings per Share
$0.27 ($0.45) $0.12 $1.62 $0.74 $1.43 $0.93 $0.79 $0.26 $0.84 $0.83
Weighted Average Diluted Shares Outstanding
46.26M 45.21M 45.89M 47.94M 43.74M 42.94M 40.56M 38.71M 36.86M 36.72M 36.62M
Weighted Average Basic & Diluted Shares Outstanding
46.76M 45.92M 44.99M 44.42M 43.04M 42.47M 39.30M 37.70M 30.20M 35.80M 35.50M

Quarterly Income Statements for Omnicell

This table shows Omnicell's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
-7.02 16 8.63 3.74 -16 -14 5.55 3.45 -15 -28 17
Consolidated Net Income / (Loss)
-7.02 16 8.63 3.74 -16 -14 5.55 3.45 -15 -28 17
Net Income / (Loss) Continuing Operations
-7.02 16 8.63 3.74 -16 -14 5.55 3.45 -15 -28 17
Total Pre-Tax Income
-9.53 24 12 8.20 -18 -19 7.38 12 -21 -36 17
Total Operating Income
-12 12 6.56 3.22 -22 -23 3.71 7.75 -23 -38 18
Total Gross Profit
111 142 122 114 93 105 132 134 125 122 159
Total Revenue
270 307 282 277 246 259 299 299 291 298 348
Operating Revenue
270 307 282 277 246 259 299 299 291 298 348
Total Cost of Revenue
159 165 160 162 154 153 167 165 166 176 189
Operating Cost of Revenue
159 165 160 162 154 153 167 165 166 176 189
Total Operating Expenses
123 129 116 111 114 129 128 127 148 160 141
Selling, General & Admin Expense
102 103 94 90 92 102 104 104 125 132 115
Research & Development Expense
21 26 21 21 22 27 24 23 23 28 25
Total Other Income / (Expense), net
2.09 11 5.06 4.97 4.02 4.85 3.67 4.46 1.78 2.84 -1.15
Other Income / (Expense), net
2.09 11 5.06 4.97 4.02 4.85 3.67 4.46 1.78 2.84 -1.15
Income Tax Expense
-2.51 7.76 3.00 4.46 -2.16 -4.14 1.83 8.76 -6.18 -7.11 0.54
Basic Earnings per Share
($0.15) $0.34 $0.19 $0.08 ($0.34) ($0.32) $0.12 $0.08 ($0.33) ($0.65) $0.38
Weighted Average Basic Shares Outstanding
46.60M 46.05M 46.15M 45.95M 45.73M 45.21M 45.33M 45.13M 44.89M 44.40M 44.44M
Diluted Earnings per Share
($0.15) $0.34 $0.19 $0.08 ($0.34) ($0.32) $0.12 $0.08 ($0.33) ($0.62) $0.37
Weighted Average Diluted Shares Outstanding
46.60M 46.26M 46.43M 46.04M 45.73M 45.21M 45.60M 45.47M 44.89M 45.89M 45.82M
Weighted Average Basic & Diluted Shares Outstanding
46.84M 46.76M 46.32M 45.99M 45.92M 45.92M 45.47M 45.21M 45.08M 44.99M 44.65M

Annual Cash Flow Statements for Omnicell

This table details how cash moves in and out of Omnicell's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Change in Cash & Equivalents
-102 148 -2.79 -134 363 60 35 -22 -28 -44 21
Net Cash From Operating Activities
188 181 78 232 186 145 104 25 50 38 65
Net Cash From Continuing Operating Activities
188 181 78 232 186 145 104 25 50 38 65
Net Income / (Loss) Continuing Operations
13 -20 5.65 78 32 61 38 31 9.76 31 31
Consolidated Net Income / (Loss)
13 -20 5.65 78 32 61 38 31 9.76 31 31
Depreciation Expense
82 87 87 73 61 54 51 52 58 26 20
Amortization Expense
11 13 16 34 17 13 2.29 1.59 1.59 0.00 0.00
Non-Cash Adjustments To Reconcile Net Income
36 76 84 47 37 32 24 18 14 12 7.47
Changes in Operating Assets and Liabilities, net
46 26 -115 0.26 39 -14 -12 -77 -34 -30 6.91
Net Cash From Investing Activities
-53 -55 -59 -412 -280 -62 -54 -35 -341 -46 -43
Net Cash From Continuing Investing Activities
-53 -55 -59 -412 -280 -62 -54 -35 -341 -46 -43
Purchase of Property, Plant & Equipment
-36 -41 -48 -29 -23 -16 -24 -15 -13 -7.54 -12
Acquisitions
0.00 0.00 2.07 -354 -225 0.00 0.00 -4.61 -314 -26 -21
Other Investing Activities, net
-16 -14 -13 -29 -32 -46 -31 -15 -14 -12 -10
Net Cash From Financing Activities
-236 23 -21 47 456 -23 -14 -9.88 264 -37 -0.21
Net Cash From Continuing Financing Activities
-235 23 -21 47 456 -23 -14 -9.88 264 -37 -0.21
Repayment of Debt
-391 -2.97 0.00 0.00 -201 -92 -77 -105 -35 0.00 0.00
Repurchase of Common Equity
0.00 0.00 -52 0.00 -53 0.00 0.00 - - -50 -24
Issuance of Debt
166 0.00 0.00 - 710 0.00 0.00 59 287 0.00 0.00
Issuance of Common Equity
39 23 40 67 106 79 70 44 18 17 22
Other Financing Activities, net
-49 3.17 -8.93 -20 -105 -9.67 -6.78 -8.29 -6.49 -3.63 2.09
Effect of Exchange Rate Changes
-1.72 -1.35 -0.94 -0.97 0.44 0.15 -1.23 -2.03 -0.06 -0.00 -0.28
Cash Interest Paid
1.62 1.44 1.44 1.92 0.52 3.58 7.49 6.55 5.34 0.08 0.06
Cash Income Taxes Paid
11 20 19 -1.73 10 7.76 3.49 7.78 11 12 9.16

Quarterly Cash Flow Statements for Omnicell

This table details how cash moves in and out of Omnicell's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
16 -194 15 28 49 38 45 62 3.17 69 15
Net Cash From Operating Activities
26 56 23 59 50 38 57 73 13 82 21
Net Cash From Continuing Operating Activities
26 56 23 59 50 38 57 73 13 82 21
Net Income / (Loss) Continuing Operations
-7.02 16 8.63 3.74 -16 -14 5.55 3.45 -15 -28 17
Consolidated Net Income / (Loss)
-7.02 16 8.63 3.74 -16 -14 5.55 3.45 -15 -28 17
Depreciation Expense
20 20 20 21 21 22 22 22 22 22 22
Amortization Expense
2.58 3.12 2.35 2.94 2.90 3.26 3.06 3.02 3.29 3.57 3.95
Non-Cash Adjustments To Reconcile Net Income
7.80 -2.84 12 16 11 17 17 16 25 19 21
Changes in Operating Assets and Liabilities, net
2.58 20 -20 15 31 10 9.93 28 -23 66 -42
Net Cash From Investing Activities
-16 -14 -13 -14 -12 -12 -14 -15 -14 -17 -16
Net Cash From Continuing Investing Activities
-16 -14 -13 -14 -12 -12 -14 -15 -14 -17 -16
Purchase of Property, Plant & Equipment
-11 -9.09 -8.87 -9.55 -8.96 -9.07 -11 -12 -10 -14 -13
Other Investing Activities, net
-4.57 -4.48 -4.47 -4.00 -3.38 -3.30 -3.56 -3.19 -3.50 -3.56 -8.59
Net Cash From Financing Activities
4.04 -234 3.55 -17 12 13 2.83 3.60 3.86 3.56 9.06
Net Cash From Continuing Financing Activities
4.04 -234 3.55 -17 12 13 2.83 3.60 3.86 3.56 9.06
Issuance of Common Equity
8.27 25 5.00 0.10 8.04 0.18 7.83 3.09 12 0.64 18
Other Financing Activities, net
-4.23 -34 -1.45 -17 3.88 16 -5.01 0.51 -8.25 2.92 -9.36
Effect of Exchange Rate Changes
1.57 -2.60 1.68 -0.25 -0.56 -0.89 -0.61 -0.03 0.18 0.48 0.70

Annual Balance Sheets for Omnicell

This table presents Omnicell's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Assets
2,121 2,227 2,211 2,142 1,825 1,241 1,081 1,016 935 579 560
Total Current Assets
815 928 882 781 829 483 397 352 315 264 283
Cash & Equivalents
369 468 330 349 486 127 67 32 54 82 126
Accounts Receivable
256 252 299 241 190 218 196 190 150 108 83
Inventories, net
89 110 148 120 96 108 101 96 69 47 32
Prepaid Expenses
26 26 27 22 16 14 21 20 29 20 24
Other Current Assets
75 72 77 48 41 15 12 13 13 7.77 7.22
Plant, Property, & Equipment, net
113 109 94 71 59 54 52 43 42 32 36
Total Noncurrent Assets
1,193 1,191 1,235 1,291 936 703 633 621 578 282 241
Noncurrent Note & Lease Receivables
53 43 33 18 22 20 17 15 21 14 11
Goodwill
735 736 734 739 499 337 336 338 328 148 123
Intangible Assets
188 211 243 278 168 125 144 168 190 90 83
Noncurrent Deferred & Refundable Income Taxes
57 33 22 16 15 14 15 9.45 4.04 2.36 1.14
Other Noncurrent Operating Assets
160 168 203 240 231 208 121 91 35 28 23
Total Liabilities & Shareholders' Equity
2,121 2,227 2,211 2,142 1,825 1,241 1,081 1,016 935 579 560
Total Liabilities
878 1,038 1,081 996 857 396 402 462 503 176 170
Total Current Liabilities
596 368 428 876 276 237 205 205 181 125 112
Short-Term Debt
174 0.00 - 488 0.00 - - 15 8.41 0.00 -
Accounts Payable
52 45 63 72 40 46 38 48 27 23 19
Accrued Expenses
168 149 173 133 80 56 43 36 31 30 19
Current Deferred Revenue
141 122 119 112 100 91 82 79 88 54 54
Current Employee Benefit Liabilities
60 52 73 71 56 44 42 27 27 18 20
Total Noncurrent Liabilities
282 670 652 120 581 159 197 257 323 52 58
Long-Term Debt
166 570 567 0.00 467 50 135 195 246 0.00 -
Noncurrent Deferred Revenue
76 59 37 20 5.67 7.08 11 11 17 18 20
Noncurrent Deferred & Payable Income Tax Liabilities
1.11 1.62 2.10 52 40 39 41 41 52 22 30
Other Noncurrent Operating Liabilities
38 40 46 48 68 62 9.56 9.83 8.21 12 7.02
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,243 1,189 1,130 1,147 968 845 680 554 432 402 390
Total Preferred & Common Equity
1,243 1,189 1,130 1,147 968 845 680 554 432 402 390
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,243 1,189 1,130 1,147 968 845 680 554 432 402 390
Common Stock
1,168 1,122 1,047 1,025 920 781 678 586 526 490 457
Retained Earnings
383 370 391 369 291 259 197 160 100 100 69
Treasury Stock
-290 - -290 -238 -238 -185 -185 -185 -185 -185 -135
Accumulated Other Comprehensive Income / (Loss)
-17 -13 -17 -8.41 -5.52 -9.45 -11 -6.11 -9.52 -2.73 -1.36

Quarterly Balance Sheets for Omnicell

This table presents Omnicell's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
2,151 2,304 2,292 2,284 2,222 2,194 2,251 2,180
Total Current Assets
840 1,011 996 990 914 881 935 849
Cash & Equivalents
387 571 557 512 447 399 340 266
Accounts Receivable
252 252 241 249 273 274 322 354
Inventories, net
91 95 93 103 116 131 141 147
Prepaid Expenses
27 29 22 27 28 24 28 25
Other Current Assets
83 65 82 99 50 54 103 57
Plant, Property, & Equipment, net
116 112 111 109 107 103 98 88
Total Noncurrent Assets
1,196 1,181 1,185 1,185 1,201 1,209 1,217 1,242
Noncurrent Note & Lease Receivables
53 51 50 44 42 35 33 34
Goodwill
736 737 735 735 734 736 735 731
Intangible Assets
183 194 199 205 219 227 235 251
Noncurrent Deferred & Refundable Income Taxes
61 42 41 37 36 33 30 17
Other Noncurrent Operating Assets
164 157 159 163 170 179 186 209
Total Liabilities & Shareholders' Equity
2,151 2,304 2,292 2,284 2,222 2,194 2,251 2,180
Total Liabilities
894 1,072 1,089 1,095 1,034 1,030 1,108 1,044
Total Current Liabilities
608 962 407 416 369 370 454 377
Short-Term Debt
175 572 - - - - - 0.00
Accounts Payable
53 48 50 43 50 47 63 74
Accrued Expenses
174 144 158 167 150 146 199 146
Current Deferred Revenue
160 152 150 165 125 125 143 114
Current Employee Benefit Liabilities
46 45 49 41 44 52 48 43
Total Noncurrent Liabilities
287 111 682 679 665 660 654 668
Long-Term Debt
167 0.00 571 570 569 568 567 566
Noncurrent Deferred Revenue
78 70 68 65 55 49 42 35
Noncurrent Deferred & Payable Income Tax Liabilities
1.17 1.41 1.33 1.49 1.57 1.51 1.56 16
Other Noncurrent Operating Liabilities
41 40 41 42 39 42 43 51
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,257 1,231 1,203 1,189 1,187 1,164 1,143 1,135
Total Preferred & Common Equity
1,257 1,231 1,203 1,189 1,187 1,164 1,143 1,135
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,257 1,231 1,203 1,189 1,187 1,164 1,143 1,135
Common Stock
1,185 1,165 1,150 1,139 1,110 1,089 1,073 1,031
Retained Earnings
376 367 358 355 385 379 376 419
Accumulated Other Comprehensive Income / (Loss)
-14 -10 -15 -15 -17 -14 -16 -24
Other Equity Adjustments
-290 - -290 - - - - -

Annual Metrics And Ratios for Omnicell

This table displays calculated financial ratios and metrics derived from Omnicell's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-3.04% -11.48% 14.48% 26.88% -0.54% 13.94% 10.47% 2.42% 43.62% 9.90% 15.85%
EBITDA Growth
49.21% -20.85% -41.68% 61.21% -23.49% 57.14% 54.93% -21.00% 1.45% 4.52% 28.81%
EBIT Growth
227.28% -719.73% -103.72% 124.90% -60.30% 107.58% 689.36% -65.23% -71.94% -4.66% 38.47%
NOPAT Growth
100.68% -1,400.99% -101.54% 170.89% -40.05% 38.23% -37.62% 368.40% -50.25% 3.69% 29.11%
Net Income Growth
161.51% -460.68% -92.74% 141.81% -47.51% 62.58% 23.63% 212.81% -68.28% 0.79% 27.27%
EPS Growth
160.00% -475.00% -92.59% 118.92% -48.25% 53.76% 17.72% 203.85% -69.05% 1.20% 23.88%
Operating Cash Flow Growth
3.66% 132.83% -66.45% 24.72% 28.18% 39.48% 318.64% -50.23% 29.66% -40.94% 17.91%
Free Cash Flow Firm Growth
48.12% 162.42% 64.49% -63.27% -416.42% 43.48% 222.94% 91.39% -1,149.32% -306.17% -54.07%
Invested Capital Growth
-5.87% -5.54% 6.27% 35.52% 23.53% 2.70% 2.16% 15.97% 97.16% 21.18% 8.08%
Revenue Q/Q Growth
4.51% -3.27% -1.02% 5.78% 0.10% 4.25% 1.99% 3.05% 6.90% 1.84% 3.71%
EBITDA Q/Q Growth
50.96% 25.69% -30.98% -2.15% 0.09% 6.12% 3.63% -0.03% 15.06% -0.78% 5.22%
EBIT Q/Q Growth
254.88% 45.81% -106.15% -9.68% -21.62% 7.81% 6.13% 48.47% 16.84% -4.50% 5.38%
NOPAT Q/Q Growth
100.67% 30.07% -102.83% -2.03% 2.65% 9.85% -30.06% 174.89% 18.41% -3.39% 8.32%
Net Income Q/Q Growth
170.85% 40.79% -88.24% -2.99% -15.08% 13.51% -30.34% 254.74% 20.43% -4.89% 8.58%
EPS Q/Q Growth
169.23% 40.00% -88.24% -5.81% -15.91% 11.72% -32.61% 259.09% 18.18% -4.55% 7.79%
Operating Cash Flow Q/Q Growth
10.54% -19.45% 40.75% -6.76% 28.86% -8.01% 71.28% -44.22% -14.82% 4.64% 33.42%
Free Cash Flow Firm Q/Q Growth
46.14% -43.27% 68.96% 8.70% -516.81% -37.51% 188.44% 3.86% -15.17% 7.71% 365.26%
Invested Capital Q/Q Growth
-1.45% -1.44% -4.77% 15.57% 26.28% 2.76% -1.59% 11.36% 4.60% -4.08% -3.82%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
42.35% 43.31% 45.45% 49.00% 46.32% 48.71% 47.29% 44.71% 45.56% 51.17% 53.04%
EBITDA Margin
10.71% 6.96% 7.78% 15.28% 12.03% 15.64% 11.34% 8.08% 10.48% 14.83% 15.60%
Operating Margin
0.03% -3.04% -0.18% 7.91% 3.98% 8.73% 5.64% 1.56% 3.08% 10.04% 11.25%
EBIT Margin
2.30% -1.75% -0.19% 5.83% 3.29% 8.24% 4.52% 0.63% 1.86% 9.54% 11.00%
Profit (Net Income) Margin
1.13% -1.78% 0.44% 6.88% 3.61% 6.84% 4.79% 4.28% 1.40% 6.35% 6.92%
Tax Burden Percent
48.96% 101.31% -230.25% 117.94% 109.69% 82.96% 105.93% 676.37% 75.19% 66.52% 62.92%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
51.04% 0.00% 0.00% -17.94% -9.69% 17.04% -5.93% -576.37% 24.82% 33.48% 37.08%
Return on Invested Capital (ROIC)
0.01% -1.84% -0.12% 9.45% 4.54% 8.58% 6.36% 11.06% 3.38% 11.07% 12.27%
ROIC Less NNEP Spread (ROIC-NNEP)
33.80% 0.55% 3.75% -36.60% 18.67% 90.18% -1.21% -12.72% -7.41% 12.60% 12.86%
Return on Net Nonoperating Assets (RNNOA)
1.02% 0.08% 0.62% -2.08% -0.99% -0.53% -0.24% -4.87% -1.04% -3.31% -4.01%
Return on Equity (ROE)
1.03% -1.76% 0.50% 7.36% 3.55% 8.05% 6.12% 6.19% 2.34% 7.76% 8.26%
Cash Return on Invested Capital (CROIC)
6.06% 3.86% -6.20% -20.72% -16.51% 5.91% 4.22% -3.73% -62.01% -8.08% 4.50%
Operating Return on Assets (OROA)
1.18% -0.91% -0.11% 3.33% 1.91% 6.37% 3.40% 0.46% 1.71% 8.12% 9.22%
Return on Assets (ROA)
0.58% -0.92% 0.26% 3.92% 2.10% 5.28% 3.60% 3.13% 1.29% 5.40% 5.80%
Return on Common Equity (ROCE)
1.03% -1.76% 0.50% 7.36% 3.55% 8.05% 6.12% 6.19% 2.34% 7.76% 8.26%
Return on Equity Simple (ROE_SIMPLE)
1.01% -1.71% 0.50% 6.79% 3.33% 7.26% 5.55% 5.51% 2.26% 7.64% 7.82%
Net Operating Profit after Tax (NOPAT)
0.17 -24 -1.63 106 39 65 47 75 16 32 31
NOPAT Margin
0.01% -2.13% -0.13% 9.33% 4.37% 7.25% 5.97% 10.58% 2.31% 6.68% 7.08%
Net Nonoperating Expense Percent (NNEP)
-33.78% -2.39% -3.88% 46.05% -14.13% -81.61% 7.56% 23.78% 10.79% -1.53% -0.59%
Return On Investment Capital (ROIC_SIMPLE)
0.01% -1.39% -0.10% - - - - - - - -
Cost of Revenue to Revenue
57.65% 56.69% 54.55% 51.00% 53.68% 51.29% 52.71% 55.29% 54.44% 48.83% 46.96%
SG&A Expenses to Revenue
34.19% 37.89% 37.53% 34.40% 34.48% 32.32% 33.42% 33.88% 34.18% 34.58% 35.49%
R&D to Revenue
8.13% 8.47% 8.10% 6.69% 7.86% 7.65% 8.24% 9.26% 8.31% 7.26% 6.31%
Operating Expenses to Revenue
42.32% 46.35% 45.63% 41.09% 42.34% 39.97% 41.65% 43.14% 42.49% 41.13% 41.80%
Earnings before Interest and Taxes (EBIT)
26 -20 -2.45 66 29 74 36 4.51 13 46 49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
119 80 101 173 107 140 89 58 73 72 69
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.66 1.44 1.99 6.91 5.25 4.05 3.57 3.32 2.87 2.74 3.02
Price to Tangible Book Value (P/TBV)
6.44 7.07 14.72 60.91 16.93 8.93 12.13 37.95 0.00 6.68 6.38
Price to Revenue (P/Rev)
1.85 1.49 1.74 7.00 5.69 3.82 3.08 2.58 1.78 2.27 2.67
Price to Earnings (P/E)
164.55 0.00 398.59 101.85 157.72 55.87 64.32 60.28 126.89 35.80 38.64
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.61% 0.00% 0.25% 0.98% 0.63% 1.79% 1.55% 1.66% 0.79% 2.79% 2.59%
Enterprise Value to Invested Capital (EV/IC)
1.67 1.40 1.82 6.27 5.33 4.36 3.34 2.76 2.28 3.18 3.99
Enterprise Value to Revenue (EV/Rev)
1.83 1.58 1.92 7.13 5.67 3.73 3.17 2.83 2.07 2.10 2.39
Enterprise Value to EBITDA (EV/EBITDA)
17.07 22.70 24.66 46.64 47.14 23.88 27.95 35.02 19.71 14.17 15.32
Enterprise Value to EBIT (EV/EBIT)
79.46 0.00 0.00 122.23 172.37 45.31 70.05 447.12 110.79 22.03 21.72
Enterprise Value to NOPAT (EV/NOPAT)
12,324.22 0.00 0.00 76.43 129.82 51.53 53.05 26.76 89.33 31.50 33.76
Enterprise Value to Operating Cash Flow (EV/OCF)
10.83 10.01 31.98 34.81 27.22 23.10 24.00 81.24 28.81 26.47 16.16
Enterprise Value to Free Cash Flow (EV/FCFF)
26.77 35.34 0.00 0.00 0.00 74.77 79.90 0.00 0.00 0.00 91.97
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.27 0.48 0.50 0.43 0.48 0.06 0.20 0.38 0.59 0.00 0.00
Long-Term Debt to Equity
0.13 0.48 0.50 0.00 0.48 0.06 0.20 0.35 0.57 0.00 0.00
Financial Leverage
0.03 0.15 0.16 0.06 -0.05 -0.01 0.20 0.38 0.14 -0.26 -0.31
Leverage Ratio
1.79 1.91 1.91 1.88 1.69 1.52 1.70 1.98 1.82 1.44 1.42
Compound Leverage Factor
1.79 1.91 1.91 1.88 1.69 1.52 1.70 1.98 1.82 1.44 1.42
Debt to Total Capital
21.51% 32.39% 33.39% 29.86% 32.56% 5.59% 16.61% 27.49% 37.06% 0.00% 0.00%
Short-Term Debt to Total Capital
11.01% 0.00% 0.00% 29.86% 0.00% 0.00% 0.00% 1.99% 1.23% 0.00% 0.00%
Long-Term Debt to Total Capital
10.50% 32.39% 33.39% 0.00% 32.56% 5.59% 16.61% 25.50% 35.83% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
78.49% 67.61% 66.61% 70.14% 67.44% 94.42% 83.39% 72.51% 62.94% 100.00% 100.00%
Debt to EBITDA
2.86 7.13 5.62 2.82 4.35 0.36 1.52 3.65 3.48 0.00 0.00
Net Debt to EBITDA
-0.24 1.27 2.34 0.80 -0.17 -0.55 0.76 3.08 2.74 0.00 0.00
Long-Term Debt to EBITDA
1.40 7.13 5.62 0.00 4.35 0.36 1.52 3.38 3.37 0.00 0.00
Debt to NOPAT
2,064.93 -23.34 -348.42 4.62 11.99 0.77 2.88 2.79 15.79 0.00 0.00
Net Debt to NOPAT
-172.60 -4.17 -145.26 1.32 -0.48 -1.19 1.45 2.36 12.41 0.00 0.00
Long-Term Debt to NOPAT
1,008.44 -23.34 -348.42 0.00 11.99 0.77 2.88 2.59 15.27 0.00 0.00
Altman Z-Score
2.35 2.01 2.33 5.59 4.68 6.65 4.93 3.50 2.59 5.38 5.77
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.37 2.52 2.06 0.89 3.00 2.04 1.94 1.72 1.74 2.12 2.52
Quick Ratio
1.05 1.96 1.47 0.67 2.45 1.46 1.29 1.08 1.13 1.53 1.86
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
76 51 -82 -231 -142 45 31 -25 -295 -24 11
Operating Cash Flow to CapEx
514.83% 436.64% 163.63% 800.25% 813.72% 912.34% 438.73% 161.88% 371.14% 510.29% 546.58%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.51 0.52 0.60 0.57 0.58 0.77 0.75 0.73 0.92 0.85 0.84
Accounts Receivable Turnover
4.38 4.16 4.80 5.25 4.37 4.33 4.08 4.19 5.39 5.08 6.24
Inventory Turnover
6.45 5.05 5.29 5.34 4.69 4.41 4.21 4.76 6.54 6.06 6.57
Fixed Asset Turnover
10.05 11.33 15.70 17.39 15.75 16.97 16.73 16.85 18.73 14.15 12.34
Accounts Payable Turnover
13.25 12.00 10.48 10.33 11.05 10.90 9.61 10.46 15.24 11.25 11.53
Days Sales Outstanding (DSO)
83.42 87.74 76.10 69.49 83.55 84.35 89.54 87.15 67.73 71.83 58.51
Days Inventory Outstanding (DIO)
56.57 72.31 69.05 68.35 77.86 82.85 86.64 76.61 55.83 60.27 55.54
Days Payable Outstanding (DPO)
27.55 30.43 34.82 35.35 33.03 33.48 37.97 34.90 23.95 32.45 31.65
Cash Conversion Cycle (CCC)
112.44 129.62 110.32 102.49 128.38 133.72 138.22 128.87 99.61 99.65 82.41
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,215 1,291 1,366 1,286 949 768 748 732 631 320 264
Invested Capital Turnover
0.89 0.86 0.98 1.01 1.04 1.18 1.06 1.05 1.46 1.66 1.73
Increase / (Decrease) in Invested Capital
-76 -76 81 337 181 20 16 101 311 56 20
Enterprise Value (EV)
2,034 1,813 2,487 8,068 5,059 3,350 2,495 2,017 1,438 1,019 1,053
Market Capitalization
2,062 1,711 2,251 7,929 5,078 3,427 2,427 1,840 1,238 1,101 1,179
Book Value per Share
$26.84 $26.15 $25.31 $26.10 $22.87 $20.15 $17.15 $14.61 $11.82 $11.36 $10.96
Tangible Book Value per Share
$6.92 $5.32 $3.43 $2.96 $7.09 $9.15 $5.05 $1.28 ($2.37) $4.65 $5.19
Total Capital
1,584 1,759 1,697 1,635 1,435 895 815 764 686 402 390
Total Debt
341 570 567 488 467 50 135 210 254 0.00 0.00
Total Long-Term Debt
166 570 567 0.00 467 50 135 195 246 0.00 0.00
Net Debt
-28 102 236 139 -19 -77 68 178 200 -82 -126
Capital Expenditures (CapEx)
36 41 48 29 23 16 24 15 13 7.54 12
Debt-free, Cash-free Net Working Capital (DFCFNWC)
25 92 123 44 67 119 125 130 88 57 45
Debt-free Net Working Capital (DFNWC)
394 560 453 393 553 246 193 162 143 139 171
Net Working Capital (NWC)
220 560 453 -95 553 246 193 147 134 139 171
Net Nonoperating Expense (NNE)
-12 -4.04 -7.27 28 6.78 3.67 9.30 45 6.34 1.59 0.68
Net Nonoperating Obligations (NNO)
-28 102 236 139 -19 -77 68 178 200 -82 -126
Total Depreciation and Amortization (D&A)
94 100 103 107 78 66 54 53 60 26 20
Debt-free, Cash-free Net Working Capital to Revenue
2.24% 8.00% 9.49% 3.86% 7.52% 13.27% 15.92% 18.22% 12.71% 11.82% 10.24%
Debt-free Net Working Capital to Revenue
35.44% 48.80% 34.98% 34.69% 61.98% 27.45% 24.46% 22.77% 20.54% 28.79% 38.80%
Net Working Capital to Revenue
19.76% 48.80% 34.98% -8.43% 61.98% 27.45% 24.46% 20.63% 19.33% 28.79% 38.80%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.27 ($0.45) $0.13 $1.79 $0.76 $1.48 $0.96 $0.55 $0.02 $0.86 $0.86
Adjusted Weighted Average Basic Shares Outstanding
46.05M 45.21M 44.40M 43.48M 42.58M 41.46M 39.24M 37.48M 36.16M 35.86M 35.65M
Adjusted Diluted Earnings per Share
$0.27 ($0.45) $0.12 $1.62 $0.74 $1.43 $0.93 $0.53 $0.02 $0.84 $0.83
Adjusted Weighted Average Diluted Shares Outstanding
46.26M 45.21M 45.89M 47.94M 43.74M 42.94M 40.56M 38.71M 36.86M 36.72M 36.62M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
46.76M 45.92M 44.99M 44.42M 43.04M 42.47M 40.80M 38.78M 36.95M 35.83M 36.17M
Normalized Net Operating Profit after Tax (NOPAT)
0.24 -24 -1.63 63 25 65 31 7.80 16 30 31
Normalized NOPAT Margin
0.02% -2.13% -0.13% 5.53% 2.79% 7.25% 3.95% 1.09% 2.31% 6.20% 7.08%
Pre Tax Income Margin
2.30% -1.75% -0.19% 5.83% 3.29% 8.24% 4.52% 0.63% 1.86% 9.54% 11.00%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 924.40% 0.00% 164.74% 0.00% 0.00% 0.00% 0.00% 162.62% 78.94%

Quarterly Metrics And Ratios for Omnicell

This table displays calculated financial ratios and metrics derived from Omnicell's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
9.55% 18.56% -5.44% -7.42% -15.30% -13.04% -14.19% -9.78% -8.84% -4.30% 17.43%
EBITDA Growth
106.33% 622.06% 6.79% -14.30% 54.79% 165.61% -25.78% 0.30% -86.58% -127.81% -13.84%
EBIT Growth
46.55% 227.45% 57.50% -32.86% 15.82% 47.86% -57.37% 13.32% -526.20% -621.96% -25.76%
NOPAT Growth
46.82% 150.88% 74.48% -32.92% 4.86% 39.09% -84.39% -79.16% -291.33% -212.75% -51.58%
Net Income Growth
55.20% 210.21% 55.41% 8.23% -4.51% 49.40% -66.90% -61.95% -282.64% -303.19% -42.78%
EPS Growth
55.88% 206.25% 58.33% 0.00% -3.03% 48.39% -67.57% -60.00% -294.12% -321.43% -39.34%
Operating Cash Flow Growth
-48.10% 46.60% -60.09% -19.48% 291.17% -53.24% 169.22% 863.30% 179.83% 37.77% -50.74%
Free Cash Flow Firm Growth
-74.88% 41.76% -36.26% 40.81% 1,031.42% 155.25% 142.10% 117.00% 97.32% 65.71% 6.17%
Invested Capital Growth
-2.82% -5.87% -5.86% -8.63% -8.97% -5.54% -8.73% -5.70% -0.33% 6.27% 28.96%
Revenue Q/Q Growth
-12.13% 8.66% 2.03% 12.45% -4.90% -13.33% -0.10% 2.87% -2.37% -14.48% 5.03%
EBITDA Q/Q Growth
-72.05% 36.67% 6.82% 405.71% -2.20% -79.79% -14.28% 813.39% 141.46% -122.87% 15.84%
EBIT Q/Q Growth
-140.38% 102.98% 41.84% 145.97% 3.70% -350.84% -39.54% 157.64% 40.36% -305.08% 60.73%
NOPAT Q/Q Growth
-197.74% 70.79% 231.65% 109.61% 6.50% -685.74% 27.50% 113.62% 40.13% -250.12% 70.19%
Net Income Q/Q Growth
-144.33% 83.57% 131.06% 123.83% -9.05% -358.87% 60.91% 123.01% 47.20% -269.36% 84.96%
EPS Q/Q Growth
-144.12% 78.95% 137.50% 123.53% -6.25% -366.67% 50.00% 124.24% 46.77% -267.57% 85.00%
Operating Cash Flow Q/Q Growth
-53.97% 147.49% -61.24% 17.51% 30.04% -32.62% -21.80% 470.89% -84.46% 287.97% 321.70%
Free Cash Flow Firm Q/Q Growth
-67.90% 3.03% -29.87% 8.31% 81.15% -53.67% 54.91% 816.46% 89.25% 64.70% 37.43%
Invested Capital Q/Q Growth
-0.27% -1.45% 1.27% -2.36% -3.41% -1.44% -1.71% -2.72% 0.23% -4.77% 1.56%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
41.14% 46.19% 43.29% 41.31% 37.63% 40.72% 44.18% 44.97% 43.02% 40.90% 45.71%
EBITDA Margin
4.84% 15.21% 12.09% 11.55% 2.57% 2.50% 10.71% 12.48% 1.41% -3.31% 12.38%
Operating Margin
-4.31% 4.04% 2.32% 1.16% -8.88% -9.03% 1.24% 2.59% -7.90% -12.89% 5.31%
EBIT Margin
-3.53% 7.69% 4.12% 2.96% -7.24% -7.15% 2.47% 4.08% -7.29% -11.93% 4.98%
Profit (Net Income) Margin
-2.60% 5.16% 3.06% 1.35% -6.37% -5.55% 1.86% 1.15% -5.16% -9.54% 4.82%
Tax Burden Percent
73.69% 67.13% 74.22% 45.57% 87.91% 77.63% 75.22% 28.27% 70.81% 79.99% 96.86%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 32.87% 25.78% 54.43% 0.00% 0.00% 24.78% 71.73% 0.00% 0.00% 3.14%
Return on Invested Capital (ROIC)
-2.79% 2.41% 1.44% 0.45% -5.24% -5.46% 0.81% 0.66% -5.11% -8.82% 5.28%
ROIC Less NNEP Spread (ROIC-NNEP)
14.96% 22.95% 7.53% 2.93% -5.51% -4.28% 2.12% 1.18% -4.70% -9.65% 4.54%
Return on Net Nonoperating Assets (RNNOA)
0.08% 0.69% 0.38% 0.23% -0.67% -0.62% 0.38% 0.25% -1.12% -1.59% 0.61%
Return on Equity (ROE)
-2.71% 3.10% 1.83% 0.68% -5.91% -6.08% 1.19% 0.91% -6.23% -10.40% 5.89%
Cash Return on Invested Capital (CROIC)
3.40% 6.06% 4.09% 6.92% 7.58% 3.86% 6.59% 4.08% -1.22% -6.20% -20.79%
Operating Return on Assets (OROA)
-1.81% 3.93% 1.94% 1.43% -3.52% -3.70% 1.33% 2.33% -4.23% -7.10% 3.08%
Return on Assets (ROA)
-1.33% 2.64% 1.44% 0.65% -3.10% -2.87% 1.00% 0.66% -2.99% -5.68% 2.98%
Return on Common Equity (ROCE)
-2.71% 3.10% 1.83% 0.68% -5.91% -6.08% 1.19% 0.91% -6.23% -10.40% 5.89%
Return on Equity Simple (ROE_SIMPLE)
1.69% 0.00% -1.44% -1.73% -1.77% 0.00% -2.90% -1.99% -1.54% 0.00% 4.23%
Net Operating Profit after Tax (NOPAT)
-8.13 8.32 4.87 1.47 -15 -16 2.79 2.19 -16 -27 18
NOPAT Margin
-3.02% 2.71% 1.73% 0.53% -6.21% -6.32% 0.93% 0.73% -5.53% -9.02% 5.14%
Net Nonoperating Expense Percent (NNEP)
-17.75% -20.55% -6.09% -2.48% 0.27% -1.17% -1.31% -0.52% -0.41% 0.83% 0.74%
Return On Investment Capital (ROIC_SIMPLE)
-0.51% 0.53% - - - -0.93% - - - -1.58% -
Cost of Revenue to Revenue
58.86% 53.81% 56.71% 58.69% 62.37% 59.28% 55.82% 55.03% 56.98% 59.10% 54.29%
SG&A Expenses to Revenue
37.84% 33.67% 33.46% 32.52% 37.54% 39.39% 34.81% 34.64% 43.05% 44.24% 33.17%
R&D to Revenue
7.61% 8.49% 7.51% 7.62% 8.96% 10.36% 8.13% 7.74% 7.87% 9.55% 7.23%
Operating Expenses to Revenue
45.45% 42.16% 40.97% 40.15% 46.50% 49.75% 42.94% 42.38% 50.92% 53.79% 40.40%
Earnings before Interest and Taxes (EBIT)
-9.53 24 12 8.20 -18 -19 7.38 12 -21 -36 17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
13 47 34 32 6.32 6.47 32 37 4.09 -9.85 43
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.30 1.66 1.63 1.03 1.13 1.44 1.71 2.85 2.31 1.99 3.39
Price to Tangible Book Value (P/TBV)
4.83 6.44 6.68 4.64 5.41 7.07 8.69 16.50 15.26 14.72 25.18
Price to Revenue (P/Rev)
1.44 1.85 1.88 1.15 1.22 1.49 1.72 2.69 2.08 1.74 2.94
Price to Earnings (P/E)
77.17 164.55 0.00 0.00 0.00 0.00 0.00 0.00 0.00 398.59 80.24
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
1.30% 0.61% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.25% 1.25%
Enterprise Value to Invested Capital (EV/IC)
1.31 1.67 1.63 1.03 1.12 1.40 1.65 2.62 2.09 1.82 2.90
Enterprise Value to Revenue (EV/Rev)
1.40 1.83 1.89 1.16 1.27 1.58 1.82 2.82 2.26 1.92 3.17
Enterprise Value to EBITDA (EV/EBITDA)
12.63 17.07 25.43 16.39 17.06 22.70 33.98 46.76 38.46 24.66 28.42
Enterprise Value to EBIT (EV/EBIT)
46.89 79.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 104.20
Enterprise Value to NOPAT (EV/NOPAT)
240.66 12,324.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 72.39
Enterprise Value to Operating Cash Flow (EV/OCF)
9.71 10.83 11.82 6.16 6.41 10.01 9.60 18.46 26.90 31.98 75.17
Enterprise Value to Free Cash Flow (EV/FCFF)
38.07 26.77 38.60 14.26 14.12 35.34 23.87 62.40 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.27 0.27 0.46 0.47 0.48 0.48 0.48 0.49 0.50 0.50 0.50
Long-Term Debt to Equity
0.13 0.13 0.00 0.47 0.48 0.48 0.48 0.49 0.50 0.50 0.50
Financial Leverage
0.01 0.03 0.05 0.08 0.12 0.15 0.18 0.22 0.24 0.16 0.13
Leverage Ratio
1.81 1.79 1.87 1.90 1.95 1.91 1.89 1.92 1.97 1.91 1.88
Compound Leverage Factor
1.81 1.79 1.87 1.90 1.95 1.91 1.89 1.92 1.97 1.91 1.88
Debt to Total Capital
21.35% 21.51% 31.72% 32.20% 32.43% 32.39% 32.39% 32.81% 33.18% 33.39% 33.26%
Short-Term Debt to Total Capital
10.92% 11.01% 31.72% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
10.43% 10.50% 0.00% 32.20% 32.43% 32.39% 32.39% 32.81% 33.18% 33.39% 33.26%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
78.65% 78.49% 68.28% 67.80% 67.57% 67.61% 67.61% 67.19% 66.82% 66.61% 66.74%
Debt to EBITDA
2.71 2.86 7.25 7.44 6.95 7.13 8.95 7.61 7.61 5.62 3.87
Net Debt to EBITDA
-0.36 -0.24 0.02 0.19 0.71 1.27 1.92 2.26 3.05 2.34 2.05
Long-Term Debt to EBITDA
1.32 1.40 0.00 7.44 6.95 7.13 8.95 7.61 7.61 5.62 3.87
Debt to NOPAT
51.68 2,064.93 -23.07 -21.32 -24.14 -23.34 -16.30 -23.12 -26.69 -348.42 9.86
Net Debt to NOPAT
-6.90 -172.60 -0.06 -0.54 -2.46 -4.17 -3.50 -6.86 -10.67 -145.26 5.22
Long-Term Debt to NOPAT
25.25 1,008.44 0.00 -21.32 -24.14 -23.34 -16.30 -23.12 -26.69 -348.42 9.86
Altman Z-Score
1.98 2.35 1.85 1.70 1.71 2.01 2.26 3.04 2.45 2.28 3.37
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.38 1.37 1.05 2.45 2.38 2.52 2.47 2.38 2.06 2.06 2.25
Quick Ratio
1.05 1.05 0.86 1.96 1.83 1.96 1.95 1.82 1.46 1.47 1.65
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
27 84 82 116 108 59 128 83 -12 -107 -304
Operating Cash Flow to CapEx
232.04% 619.73% 256.59% 614.60% 557.70% 423.53% 536.18% 626.80% 125.92% 600.75% 165.92%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.51 0.51 0.47 0.48 0.49 0.52 0.54 0.57 0.58 0.60 0.62
Accounts Receivable Turnover
4.54 4.38 4.06 4.20 3.86 4.16 3.78 4.23 4.14 4.80 4.45
Inventory Turnover
6.64 6.45 5.96 5.68 5.22 5.05 5.11 4.95 5.06 5.29 5.51
Fixed Asset Turnover
10.10 10.05 9.74 10.09 10.63 11.33 12.15 13.35 14.45 15.70 17.08
Accounts Payable Turnover
13.41 13.25 12.88 13.12 11.98 12.00 10.90 12.03 10.42 10.48 9.35
Days Sales Outstanding (DSO)
80.36 83.42 89.92 86.99 94.44 87.74 96.44 86.34 88.18 76.10 81.94
Days Inventory Outstanding (DIO)
54.94 56.57 61.22 64.22 69.95 72.31 71.41 73.80 72.14 69.05 66.21
Days Payable Outstanding (DPO)
27.22 27.55 28.33 27.81 30.47 30.43 33.49 30.35 35.02 34.82 39.03
Cash Conversion Cycle (CCC)
108.08 112.44 122.81 123.40 133.92 129.62 134.36 129.78 125.30 110.32 109.12
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,212 1,215 1,233 1,217 1,247 1,291 1,309 1,332 1,369 1,366 1,435
Invested Capital Turnover
0.92 0.89 0.84 0.85 0.84 0.86 0.86 0.90 0.92 0.98 1.03
Increase / (Decrease) in Invested Capital
-35 -76 -77 -115 -123 -76 -125 -81 -4.53 81 322
Enterprise Value (EV)
1,589 2,034 2,007 1,258 1,400 1,813 2,158 3,490 2,866 2,487 4,154
Market Capitalization
1,635 2,062 2,005 1,243 1,342 1,711 2,036 3,321 2,639 2,251 3,854
Book Value per Share
$26.88 $26.84 $26.77 $26.19 $25.89 $26.15 $26.26 $25.81 $25.40 $25.31 $25.64
Tangible Book Value per Share
$7.24 $6.92 $6.53 $5.84 $5.40 $5.32 $5.18 $4.47 $3.84 $3.43 $3.46
Total Capital
1,598 1,584 1,803 1,774 1,759 1,759 1,756 1,732 1,710 1,697 1,701
Total Debt
341 341 572 571 570 570 569 568 567 567 566
Total Long-Term Debt
167 166 0.00 571 570 570 569 568 567 567 566
Net Debt
-46 -28 1.37 14 58 102 122 169 227 236 299
Capital Expenditures (CapEx)
11 9.09 8.87 9.55 8.96 9.07 11 12 10 14 13
Debt-free, Cash-free Net Working Capital (DFCFNWC)
20 25 51 32 61 92 98 112 141 123 206
Debt-free Net Working Capital (DFNWC)
407 394 622 589 574 560 544 511 481 453 472
Net Working Capital (NWC)
232 220 50 589 574 560 544 511 481 453 472
Net Nonoperating Expense (NNE)
-1.11 -7.52 -3.76 -2.27 0.38 -1.98 -2.76 -1.26 -1.07 1.56 1.11
Net Nonoperating Obligations (NNO)
-46 -28 1.37 14 58 102 122 169 227 236 299
Total Depreciation and Amortization (D&A)
23 23 23 24 24 25 25 25 25 26 26
Debt-free, Cash-free Net Working Capital to Revenue
1.75% 2.24% 4.80% 2.94% 5.55% 8.00% 8.23% 9.05% 11.09% 9.49% 15.74%
Debt-free Net Working Capital to Revenue
35.81% 35.44% 58.42% 54.47% 52.02% 48.80% 45.90% 41.38% 37.94% 34.98% 36.08%
Net Working Capital to Revenue
20.44% 19.76% 4.67% 54.47% 52.02% 48.80% 45.90% 41.38% 37.94% 34.98% 36.08%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.15) $0.34 $0.19 $0.08 ($0.34) ($0.32) $0.12 $0.08 ($0.33) ($0.65) $0.38
Adjusted Weighted Average Basic Shares Outstanding
46.60M 46.05M 46.15M 45.95M 45.73M 45.21M 45.33M 45.13M 44.89M 44.40M 44.44M
Adjusted Diluted Earnings per Share
($0.15) $0.34 $0.19 $0.08 ($0.34) ($0.32) $0.12 $0.08 ($0.33) ($0.62) $0.37
Adjusted Weighted Average Diluted Shares Outstanding
46.60M 46.26M 46.43M 46.04M 45.73M 45.21M 45.60M 45.47M 44.89M 45.89M 45.82M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
46.84M 46.76M 46.32M 45.99M 45.92M 45.92M 45.47M 45.21M 45.08M 44.99M 44.65M
Normalized Net Operating Profit after Tax (NOPAT)
-8.13 8.32 4.87 2.26 -15 -16 2.79 5.42 -16 -27 18
Normalized NOPAT Margin
-3.02% 2.71% 1.73% 0.82% -6.21% -6.32% 0.93% 1.81% -5.53% -9.02% 5.14%
Pre Tax Income Margin
-3.53% 7.69% 4.12% 2.96% -7.24% -7.15% 2.47% 4.08% -7.29% -11.93% 4.98%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 924.40% 108.69%

Frequently Asked Questions About Omnicell's Financials

When does Omnicell's financial year end?

According to the most recent income statement we have on file, Omnicell's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Omnicell's net income changed over the last 10 years?

Omnicell's net income appears to be on a downward trend, with a most recent value of $12.53 million in 2024, falling from $30.52 million in 2014. The previous period was -$20.37 million in 2023. See where experts think Omnicell is headed by visiting Omnicell's forecast page.

What is Omnicell's operating income?
Omnicell's total operating income in 2024 was $337 thousand, based on the following breakdown:
  • Total Gross Profit: $471.00 million
  • Total Operating Expenses: $470.67 million
How has Omnicell revenue changed over the last 10 years?

Over the last 10 years, Omnicell's total revenue changed from $440.90 million in 2014 to $1.11 billion in 2024, a change of 152.3%.

How much debt does Omnicell have?

Omnicell's total liabilities were at $877.65 million at the end of 2024, a 15.4% decrease from 2023, and a 415.9% increase since 2014.

How much cash does Omnicell have?

In the past 10 years, Omnicell's cash and equivalents has ranged from $32.42 million in 2017 to $485.93 million in 2020, and is currently $369.20 million as of their latest financial filing in 2024.

How has Omnicell's book value per share changed over the last 10 years?

Over the last 10 years, Omnicell's book value per share changed from 10.96 in 2014 to 26.84 in 2024, a change of 145.0%.



This page (NASDAQ:OMCL) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners